Influence of light cycle on response to 5-HT(1A) ligands in punished responding in rats

Behavioural Pharmacology

Volumn 10, Issue 8, 1999, Pages 785-791

  Gleason, S D ^a   Leander, J D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT(1A) receptors; Circadian rhythms; Punished responding; Rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANXIOLYTIC AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DARKNESS; DRUG EFFECT; LIGHT; MALE; MAZE TEST; MODEL; NONHUMAN; RAT; TRANQUILIZING ACTIVITY;

EID: 0033385028     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199912000-00010     Document Type: Article

References (51)

1. Ahlers ST, Weissman BA, Barrett JE (1992). Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons. J Pharmacol Exp Ther 260:474-481.
2. Barrett JE (1984). Behavioral principles in psychopharmacology. In: Aspects of Psychopharmacology, Sanger DJ, Blackman DE (editors). London: Methuen, pp. 21-56.
3. 1A drugs in the pigeon. Drug Dev Res 26:299-317.
4. Barrett JE, Gleeson S (1992). Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190. Eur J Pharmacol 217:163-171.
5. Barrett JE, Vanover KE (1993). 5-HT receptors as targets for the development of novel anxiolytic drugs:models, mechanisms and future directions. Psychopharmacology 112:1-12.
6. 1A agonists in pigeons are dependent on the level of response suppression. Behav Pharmacol 6:540-550.
7. Cao BJ, Rodgers RJ (1998). Comparative effects of novel 5HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice. Psychopharmacology 139:185-194.
8. Cervo L, Samanin R (1995). 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats. Pharmacol Biochem Behav 52:671-676.
9. Currie PJ, Coscina DV (1993). Diurnal variations in the feeding response to 8-OH-DPAT injected into the dorsal or median raphe. NeuroReport 4:1105-1107.
10. 2A mediated behavior in mice during the day but not at night. J Neural Transm 105:635-643.
11. Deacon R, Gardner CR (1986). Benzodiazepine and 5-HT ligands in a rat conflict test. Br J Pharmacol 88:330.
12. Dreshfield IJ, Rocco VP, Wond DT (1997). Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours. Chin J Physiol 40:57-61.
13. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169:1-10.
14. Engleman EA, Robertson DW, Thompson DC, Perry KW, Wong DT (1996). Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus. J Neurochem 66:599-603.
15. Eison AS, Eison MS (1994). Serotonergic mechanisms in anxiety. Prog Neuropsychopharmacol Biol Psychiatry 18:47-62.
16. Eison AS, Eison MS, Stanley M, Riblet LA (1986). Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 24:701-707.
17. Engel JA, Hjorth S, Svensson K, Carlsoson A, Liljequist S (1984). Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT). Eur J Pharmacol 105:365-368.
18. 1A receptor agonist with high potency and selectivity. J Pharmacol Exp Ther 270:1270-1281.
19. Fuller RW, Perry KW, Hemrick-Luecke SK, Engleman E (1996). Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus. J Pharm Pharmacol 48:68-70.
20. Fulton B, Brogden RN (1997). Buspirone: An updated review of its clinical pharmacology and therapeutic applications. CNS Drugs 7:68-88.
21. Geller I, Seifter J (1960). The effects of mebrobamate, barbituates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492.
22. Gleeson S, Ahlers ST, Mansbach RS, Foust JM, Barrett JE (1989). Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809-817.
23. 1A partial agonists. What is their future? Drugs 41:11-18.
24. 1A antagonist is determined by arousal state. J Pyschopharmacol 8:A13.
25. Handley SL, McBlane JW (1993). 5-HT drugs in animal models of anxiety. Psychopharmacology 112:13-21.
26. Handley SL, Mithani S (1984). Effects of alpha-adrenoreceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behavior. Naunyn Schmiedebergs Arch Pharmacol 327:1-5.
27. 1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology Berl 106:261-267.
28. Jann MW (1988). Buspirone:an update on a uniquie anxiolytic agent. Pharmacotherapy 8:100-116.
29. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 272:920-929.
30. King CM, Gommans J, Joordens RJ, Hijzen TH, Maes RA, Olivier B (1997). Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat. Eur J Pharmacol 325:121-128.
31. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185.
32. Lu JQ, Nagayama H (1996). Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats. Psychopharmacology 123:42-45.
33. Lu JQ, Nagayama H (1997). Circadian rhythm in the hypothermic response to serotonin 1A receptor agonist 8OH-DPAT in rats. Chronobiol Int 14:267-273.
34. Mansbach RS, Harrod C, Hoffman SM, Nader MA, Lei Z, Witkin JM et al. (1988). Behavioral studies with anxiolytic drugs. V. behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246:114-120.
35. Montgomery KC (1955). The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 48:254-260.
36. Morrison CF, Stephenson JA (1970). Drug effects on a measure of unconditioned avoidance in the rat. Psychopharmacologia 18:133-143.
37. Moser PC (1991). The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice. Eur J Pharmacol 193:165-172.
38. Nagayama H, Lu JQ (1998). Circadian and circannual rhythms in the function of central 5-HT1A receptors in laboratory rats. Psychopharmacology 135:279-283.
39. Pellow S, File SE (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525-529.
40. Pellow S, Chopiun P, File SE, Briley M (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167.
41. Pellow S, Johnston AL, File SE (1987). Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze in the rat. J Pharmacol Exp Ther 39:917-928.
42. Pollard GT, Howard JL (1990). Effects of drugs on punished behavior; Pre-clinical test for anxiolytics. Pharmacol Ther 45:403-424.
43. 1A receptor antagonists. Cambridge, England: British Association of Psychopharmacology.
44. Sanger DJ (1987). Effects of drugs on schedule-controlled behavior. In: Experimental Psychopharmacology, Concepts and Methods. Greenshaw AJ, Dourish CT (editors). Clifton, NJ: Humana, pp. 213-248.
45. Sanger DJ, Joly D, Zikovic B (1985). Behavioral effects of nonbenzodiazepine anxiolytic drugs: A comparison of CGS 9896 and zapiclone with chlordiazepoxide. J Pharmacol Exp Ther 232:831-837.
46. Schreiber R, De Vry J (1993). 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of action? Prog Neuropsychopharmacol Biol Psychiatry 17:87-104.
47. Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG (1991). Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. Eur J Pharmacol 176:331-340.
48. 1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259-265.
49. Taylor DP, Eison MS, Riblet LA, Vandermaelen CP (1985). Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23:687-694.
50. Treit D (1985). Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203-222.
51. Weissman BA, Barrett JE, Brady LS, Witkin JM, Mendelson WB, Paul SM et al. (1984). Behavioral and neurochemical studies on the anticonflict actions of buspirone. Drug Dev Res 4:83-93.